Project description DEENESFRITPL Reduce waist size with microalgae Worldwide, obesity has nearly tripled in the last 30 years. In Europe, weight problems and obesity are increasing at a rapid rate, with over half of the EU’s population overweight. The EU-funded FUCOPRO project may have found a solution to the epidemic of obesity. It aims to increase commercial production of fucoxanthin – a natural antioxidant with unique qualities to modulate specific gene and protein expression, which in turn can prevent fat accumulation. The project will work towards ensuring commercial fucoxanthin production from the microalgae Isochrysis galbana. This production method has high concentration of fucoxanthin, is sustainable, cost effective and easily scalable to meet increasing market needs. Show the project objective Hide the project objective Objective Obesity has already reached epidemic proportions. In 2016 more than 1.9 billion adults worldwide were overweight, thereof 650 million obese. In Europe alone weight problems and obesity are increasing at a rapid rate with over 50% of EU's population overweight in 2014. Alone, adult obesity takes up roughly 7% of national healthcare expenditure of individual countries and is estimated to cost the EU 70 billion euros annually through healthcare costs and lost productivity. Current solutions are not working. This is where Algalif's revolutionary solution - a commercial fucoxanthin production from the microalgae Isochrysis galbana - comes into play. Through current product of astaxanthin, Algalíf Iceland has developed a niche in the global microalgae arena in optimizing cultivation parameters. The in-house designed photo-bio-reactor (PBR) cultivation system, with full contamination control and no supply disruptions, ensures optimal growth of the microalgae. Currently, it delivers the highest industry reported yield of a pure product (7%). This sustainable production method will be adapted to the production of fucoxanthin - a natural antioxidant with unique qualities to modulate specific gene and protein expression which in turn can prevent fat accumulation. The unique qualities of the compound are known but current methods of harvesting fucoxanthin from brown seaweed (macroalgae) hinder market growth due to; 1) concentration of fucoxanthin is significantly lower than in microalgae; 2) harvesting is time-consuming and seasonal; 3) seaweed is foodstuff in many parts of the world; 4) it is not sustainable due to climate change. Algalíf's production has high concentration of fucoxanthin, it is sustainable, cost-effective and easily scalable to meet increasing market needs. If successfully brought to market, it will be the first commercially available fucoxanthin product from Isochrysis microalgae. Fields of science engineering and technologyother engineering and technologiesfood technologynatural sciencesbiological sciencesbiochemistrybiomoleculesproteinsnatural sciencesearth and related environmental sciencesatmospheric sciencesclimatologyclimatic changessocial scienceseconomics and businesseconomicssustainable economymedical and health scienceshealth sciencesnutritionobesity Programme(s) H2020-EU.2.3. - INDUSTRIAL LEADERSHIP - Innovation In SMEs Main Programme H2020-EU.3. - PRIORITY 'Societal challenges H2020-EU.2.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies Topic(s) EIC-SMEInst-2018-2020 - SME instrument Call for proposal H2020-EIC-SMEInst-2018-2020 See other projects for this call Sub call H2020-SMEInst-2018-2020-1 Funding Scheme SME-1 - SME instrument phase 1 Coordinator ALGALIF ICELAND EHF Net EU contribution € 50 000,00 Address Bogatrod 10 262 Reykjanesbaer Iceland See on map Region Ísland Ísland Landsbyggð Activity type Private for-profit entities (excluding Higher or Secondary Education Establishments) Links Contact the organisation Opens in new window Participation in EU R&I programmes Opens in new window HORIZON collaboration network Opens in new window Other funding € 21 429,00
